FDA Inspection
Auro PR IncAuro PR Inc – FDA Inspection, May 31, 2023
Record Details
This FDA Inspection record concerns Auro PR Inc, with an inspection on May 31, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 6bba1d6e-0e9b-441e-93ca-891ed25548c5
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1207365
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.165(b)Microbiological testing
- 21 CFR 211.166(a)(4)Testing in same container - closure system
- 21 CFR 211.165(b)Microbiological testing
- 21 CFR 211.166(a)(4)Testing in same container - closure system
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Auro PR Inc
8| Date | Classification | Office | Project area |
|---|---|---|---|
| March 15, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 24, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 22, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 24, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 7, 2012 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Auro PR Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.